On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...
"Artificial Intelligence is a tool that really levels up and creates almost like an equity for everybody to participate and, when used effectively, to...
"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can...